Scientific Opinion on the substantiation of health claims related to selenium and maintenance of normal hair (ID 281), maintenance of normal nails (ID 281), protection against heavy metals (ID 383), maintenance of normal joints (ID 409), maintenance of normal thyroid function (ID 410, 1292), protection of DNA, proteins and lipids from oxidative damage (ID 410, 1292), and maintenance of the normal function of the immune system (ID 1750) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

被引:3
|
作者
Agostoni, Carlo [1 ]
Bresson, Jean-Louis [1 ]
Fairweather-Tait, Susan [1 ]
Flynn, Albert [1 ]
Golly, Ines [1 ]
Korhonen, Hannu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Neuhaeuser-Berthold, Monika [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Sanz, Yolanda [1 ]
Strain, Sean [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Selenium; minerals; hair; nails; heavy metals; joints; thyroid; immune system; health claims;
D O I
10.2903/j.efsa.2010.1727
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to selenium and maintenance of normal hair, maintenance of normal nails, protection against heavy metals, maintenance of normal joints, maintenance of normal thyroid function, protection of DNA, proteins and lipids from oxidative damage, and maintenance of the normal function of the immune system. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is selenium, which is a well recognised nutrient and is measurable in foods by established methods. The Panel considers that selenium is sufficiently characterised. Maintenance of normal hair The claimed effect is "hair and nail formation". The target population is assumed to be the general population. The Panel considers that maintenance of normal hair is a beneficial physiological effect. Deficiency in selenium has been shown to result in various disorders including impairment of hair. The Panel concludes that a cause and effect relationship has been established between the dietary intake of selenium and maintenance of normal hair. However, the evidence provided does not establish that inadequate intake of selenium leading to impaired maintenance of normal hair occurs in the general EU population. Maintenance of normal nails The claimed effect is "hair and nail formation". The target population is assumed to be the general population. The Panel considers that maintenance of normal nails is a beneficial physiological effect. Deficiency in selenium has been shown to result in various disorders including impairment of nails. The Panel concludes that a cause and effect relationship has been established between the dietary intake of selenium and maintenance of normal nails. However, the evidence provided does not establish that inadequate intake of selenium leading to impaired maintenance of normal nails occurs in the general EU population. Protection against heavy metals The claimed effect is "detoxification". The target population is assumed to be the general population. The Panel considers that protection against heavy metals is a beneficial physiological effect. No conclusions can be drawn from the only reference provided for the scientific substantiation of the claimed effect. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the dietary intake of selenium and protection against heavy metals. Maintenance of normal joints The claimed effect is "joint function". The target population is assumed to be the general population. The Panel considers that maintenance of normal joints is a beneficial physiological effect. No conclusions can be drawn from the references provided for the scientific substantiation of the claimed effect. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the dietary intake of selenium and maintenance of normal joints. Maintenance of normal thyroid function The claimed effects are "key function within metabolism (e.g. GSH-peroxidase)", "antioxidant to prevent oxidative stress", "proper thyroid function" and "maintenance of cellular redox status". The target population is assumed to be the general population. A claim on selenium and normal thyroid function has already been assessed with a favourable outcome. Protection of DNA, proteins and lipids from oxidative damage The claimed effects are "key function within metabolism (e.g. GSH-peroxidase)", "antioxidant to prevent oxidative stress", "proper thyroid function" and "maintenance of cellular redox status". The target population is assumed to be the general population. A claim on selenium and protection of DNA, proteins and lipids from oxidative damage has already been assessed with a favourable outcome. Maintenance of the normal function of the immune system The claimed effect is "natural defences/immune system". The target population is assumed to be the general population. A claim on selenium and normal function of the immune system has already been assessed with a favourable outcome. Conditions and possible restrictions of use The Panel considers that in order to bear the claims a food should be at least a source of selenium as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Scientific Opinion on the substantiation of health claims related to zeaxanthin and maintenance of normal vision (ID 1684, 2169, 2888) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (10)
  • [42] Scientific Opinion on the substantiation of health claims related to acetic acid and maintenance of normal blood pressure (ID 1447) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [43] Scientific Opinion on the substantiation of health claims related to sodium and maintenance of normal muscle function (ID 359) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    -Tait, Susan Fairweather
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    Van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)
  • [44] Scientific Opinion on the substantiation of health claims related to rapeseed oil and maintenance of normal blood LDL-cholesterol concentrations (ID 580, 581, 1408) and maintenance of normal blood HDL-cholesterol concentrations (ID 1408) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (04)
  • [45] Scientific Opinion on the substantiation of health claims related to chromium and contribution to normal macronutrient metabolism (ID 260, 401, 4665, 4666, 4667), maintenance of normal blood glucose concentrations (ID 262, 4667), contribution to the maintenance or achievement of a normal body weight (ID 339, 4665, 4666), and reduction of tiredness and fatigue (ID 261) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (10)
  • [46] Opinion on the substantiation of health claims related to alpha-linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [47] Scientific Opinion on the substantiation of health claims related to folate and contribution to normal psychological functions (ID 81, 85, 86, 88), maintenance of normal vision (ID 83, 87), reduction of tiredness and fatigue (ID 84), cell division (ID 195, 2881) and contribution to normal amino acid synthesis (ID 195, 2881) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (10)
  • [48] Scientific Opinion on the substantiation of health claims related to coenzyme Q(10) and contribution to normal energy- yielding metabolism (ID 1508, 1512, 1720, 1912, 4668), maintenance of normal blood pressure (ID 1509, 1721, 1911), protection of DNA, proteins and lipids from oxidative damage (ID 1510), contribution to normal cognitive function (ID 1511), maintenance of normal blood cholesterol concentrations (ID 1721) and increase in endurance capacity and/or endurance performance (ID 1913) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (10)
  • [49] Scientific Opinion on the substantiation of health claims related to astaxanthin and protection of the skin from UV-induced damage (ID 1687, 1979), defence against Helicobacter pylori (ID 1686), contribution to normal spermatogenesis (ID 1688), contribution to normal muscle function (ID 1685), and "immune system" (ID 1689, 1919, 1980) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (06)